PMID- 35965680 OWN - NLM STAT- MEDLINE DCOM- 20220816 LR - 20221207 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 2022 DP - 2022 TI - Clinical Effect of Abdominal Massage Therapy on Blood Glucose and Intestinal Microbiota in Patients with Type 2 Diabetes. PG - 2286598 LID - 10.1155/2022/2286598 [doi] LID - 2286598 AB - The aim of the study was to investigate the clinical effects of abdominal massage on patients with type 2 diabetes mellitus (T2DM) and its influence on the intestinal microflora. We conducted a randomized, controlled clinical trial. A total of 60 patients with T2DM, who met the inclusion criteria, were randomly allocated to the control group, the routine massage group, and the abdominal massage group. The control group received health education and maintained their hypoglycemic drug treatment plan. The routine massage group and the abdominal massage group received different massage interventions. In addition to glucose and lipid metabolism indicators, we quantitatively analyzed the gut microbiota to assess the effects of massage on the intestinal microflora of patients with T2DM. Compared with the control group, the abdominal massage improved levels of glycated hemoglobin, total cholesterol, Enterobacter, and Bifidobacteria with significant differences (P = 0.02, P = 0.03, P = 0.03, and P = 0.03). The comparison within group showed that the levels of the four bacterial genera in the abdominal massage group revealed significant differences before and after treatment (P = 0.006, P < 0.001, P < 0.001, and P = 0.002). The comparison between the routine massage group and the abdominal massage group was not significantly different in all levels of test indices. The abdominal massage group regulated levels of Enterobacter and Lactobacilli to a greater extent than the routine massage group. Additionally, abdominal massage decreased Enterococcus levels. The results of this study showed that abdominal massage has clinical advantages over routine massage. Specifically, this intervention may correct microflora disturbances to a certain extent. CI - Copyright (c) 2022 Ying Xie et al. FAU - Xie, Ying AU - Xie Y AUID- ORCID: 0000-0002-9535-8958 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Huan, Meng-Ting AU - Huan MT AUID- ORCID: 0000-0002-9641-9687 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Sang, Jia-Jia AU - Sang JJ AUID- ORCID: 0000-0003-1257-2498 AD - Provincial Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, China. FAU - Luo, Song-Song AU - Luo SS AUID- ORCID: 0000-0002-8547-8817 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Kong, Xin-Tian AU - Kong XT AUID- ORCID: 0000-0002-3898-7459 AD - Changzhou Hospital of Traditional Chinese Medicine, Changzhou, Jiangsu, China. FAU - Xie, Zhou-Yu AU - Xie ZY AUID- ORCID: 0000-0003-2028-949X AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Zheng, Shi-Hui AU - Zheng SH AUID- ORCID: 0000-0002-1819-6959 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Wei, Qing-Bo AU - Wei QB AUID- ORCID: 0000-0002-3577-5661 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. FAU - Wu, Yun-Chuan AU - Wu YC AUID- ORCID: 0000-0002-7059-9229 AD - College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20220803 PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) SB - IM MH - Blood Glucose MH - *Diabetes Mellitus, Type 2/therapy MH - *Gastrointestinal Microbiome MH - Glycated Hemoglobin MH - Humans MH - Massage/methods PMC - PMC9365616 COIS- The authors declare no conflicts of interest. EDAT- 2022/08/16 06:00 MHDA- 2022/08/17 06:00 PMCR- 2022/08/03 CRDT- 2022/08/15 03:28 PHST- 2022/05/05 00:00 [received] PHST- 2022/07/12 00:00 [revised] PHST- 2022/07/25 00:00 [accepted] PHST- 2022/08/15 03:28 [entrez] PHST- 2022/08/16 06:00 [pubmed] PHST- 2022/08/17 06:00 [medline] PHST- 2022/08/03 00:00 [pmc-release] AID - 10.1155/2022/2286598 [doi] PST - epublish SO - Oxid Med Cell Longev. 2022 Aug 3;2022:2286598. doi: 10.1155/2022/2286598. eCollection 2022.